Adma Biologics (ADMA) Long-Term Deferred Tax (2015 - 2026)

Adma Biologics (ADMA) has 6 years of Long-Term Deferred Tax data on file, last reported at $73.3 million in Q4 2025.

• Quarterly Long-Term Deferred Tax fell 13.07% year-over-year to $73.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $73.3 million (down 13.07% YoY) and the FY2025 annual result came in at $73.3 million, down 13.07% from the prior year.
• Long-Term Deferred Tax eased to $73.3 million in Q4 2025, from $74.4 million in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $84.3 million in Q4 2024 to a low of $73.3 million in Q4 2025.